ArticleOncoimmunology

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

Tiphaine Delaunay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.